THOMAS A BUCHHOLZ to Prostatic Neoplasms
This is a "connection" page, showing publications THOMAS A BUCHHOLZ has written about Prostatic Neoplasms.
Connection Strength
0.108
-
Defining the value framework for prostate brachytherapy using patient-centered outcome metrics and time-driven activity-based costing. Brachytherapy. 2016 May-Jun; 15(3):274-282.
Score: 0.042
-
Physician variation in management of low-risk prostate cancer: a population-based cohort study. JAMA Intern Med. 2014 Sep; 174(9):1450-9.
Score: 0.038
-
A survey of current clinical practice of permanent prostate brachytherapy in the United States. Int J Radiat Oncol Biol Phys. 1998 Jan 15; 40(2):461-5.
Score: 0.012
-
Niraparib (MK-4827), a novel poly(ADP-Ribose) polymerase inhibitor, radiosensitizes human lung and breast cancer cells. Oncotarget. 2014 Jul 15; 5(13):5076-86.
Score: 0.009
-
MK-1775, a novel Wee1 kinase inhibitor, radiosensitizes p53-defective human tumor cells. Clin Cancer Res. 2011 Sep 01; 17(17):5638-48.
Score: 0.008